|
|
|
|
|
by jmzachary
6567 days ago
|
|
Then we are in the same club. I've published research on global optimization algorithms for protein folding. I'm not a biochemist, but I understood that protein folding actually has immediate application in understanding disease and drug design. As a computer scientist, I also understood that compiler optimization is a mature field with most of the low-hanging fruit already picked. So, I guess I'm confused and will ask respectfully what problems in compiler optimization make it a thousand times more useful than protein folding and associated medical problems? |
|
Short answer:
Compilers are used for real work, every day. Nobody is using protein structure prediction for anything practical, and they likely won't be for decades more. At this point, it's blue-sky research.
Long answer:
"Immediate application" is one of those bits of academic-speak that really means "is related to", but sounds better to grant review boards. While it's true that protein folding is important (after all, most biological processes are mediated by folded proteins), it's not true that protein structure prediction is important. It would be great if we could predict protein structures accurately, but we can't, and until we can, it's not a practically useful discipline.
Even the very best, crystallographically determined protein structures are barely sufficient to do rational drug design, and predicted structures don't come close to that level of quality. For example: we can sometimes (very rarely) predict very small (<150 residue) protein structures to within 1 angstrom RMSD of their experimentally determined shapes (i.e. >2 angstrom resolution, in the best case). However, the interactions important to drug binding, protein design, etc., don't start until a tenth of that (scales of ~0.1 angstrom).
Throw in the fact that the vast majority of proteins are much larger than 150 angstroms, and that we keep creating cheaper, faster, more automated ways of getting actual experimental information on structure, and the role of protein structure prediction looks increasingly marginalized. It's definitely a cool, fun problem -- just not a very practical one.
For whatever it's worth, my first papers were on applying the state-of-the-art method (you've heard of it...I think you're paraphrasing the lab's PR) for protein structure prediction to genome annotation. To call the approach useful was/is a stretch, and that's for a much easier application than drug design (in fact, we were trying to find a practical application for protein structure prediction, and it was the most likely thing we could think of!)